Bristol Myers Squibb has been a long-time partner of the Department of Chemistry, sponsoring research and supporting Princeton's pipeline of early-career chemists.
Overview
A global pharmaceutical company based in Princeton's Central New Jersey backyard, Bristol Myers Squibb has collaborated with Princeton researchers to advance synthetic organic chemistry. The company has also actively supported and tapped into Princeton's pipeline of up-and-coming chemists, underwriting lecturerships and fellows, hosting student interns and participating in career development activities for undergraduate and graduate students.
In 1983, Bristol Myers Squibb established an endowed Squibb Professorship in Molecular Biology, which is currently held by Bonnie Bassler.
Princeton Catalysis Initiative
In 2019, BMS joined an elite group of biopharma companies as a founding sponsor of the Princeton Catalysis Initiative (PCI). PCI is an innovative effort to catalyze interdisciplinary collaborations between industry and molecular, physical, biological, and social scientists who conduct high-impact research across disparate fields of study. By uniting historically distinct areas, PCI aims to unleash new thinking and accelerate the creation of novel technologies and groundbreaking applications. Professor of Chemistry David Macmillan, a 2021 Nobel laureate in chemistry, led the creation of the Princeton Catalysis Initiative. Through the Initiative, BMS has participated in annual symposiums and research collaborations with Princeton researchers and other PCI members.
For more information on Princeton research sponsored by Bristol Myers Squibb, search the Research with Princeton database.
Contact Us to Collaborate
- Dean R. EdelmanStrategic Partnerships and EngagementOffice Phone:609-258-6214Email:[email protected]
Spotlight Features
Paul Chirik (l), the Edwards S. Sanford Professor of Chemistry; and Reginald Mills, a postdoc in the Chirik Lab and the first author of the research article.
Photo by Jonathan Darmon
July 27, 2023- August 29, 2022
David MacMillan, the James S. McDonnell Distinguished University Professor in Chemistry and recipient earlier this month of the Nobel Prize in chemistry, was one of four original faculty founders of the Princeton Catalysis Initiative. He has frequently characterized the symposium as “speed-dating for scientists” for its ability to introduce, package, and accelerate ideas for new collaborations. Photo by David Kelly Crow
October 28, 2021Princeton chemists Benjamin Shields and Abigail Doyle worked with computer scientist Ryan Adams (not pictured) to create machine learning software that can optimize reactions — using artificial intelligence to speed through thousands of reactions that chemists used to have to labor through one by one.
Photo by C. Todd Reichart, Department of Chemistry
February 3, 2021
Related News

David MacMillan’s team at Princeton University found a new way to use ordinary blue light shining on an iron catalyst to create carbon-carbon bonds that are otherwise difficult to form. The molecules constructed through this process fit with drug targets as precisely as “a key going into a lock,” said researchers.
Photo by Sameer A. Khan/Fotobuddy
- November 1, 2021
- July 31, 2020
- January 1, 2019
- August 6, 2018